Macquarie said that the sector is currently at a turning point, driven by increased pharmaceutical outsourcing due to drug pricing pressures and geopolitical factors, prompting a global restructuring of the pharmaceutical supply chain.
US economy set to slow, but recession unlikely: Richard Yetsenga
ANZ Group’s Richard Yetsenga anticipates a US economic slowdown in the latter half of the year, stopping short of a recession. Despite economists’ bearish outlook,